 Connection
Eric Lavonas to Snake Bites
This is a "connection" page, showing publications Eric Lavonas has written about Snake Bites.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
10.504 |
|
|
|
-
Lavonas EJ, Burnham RI, Schwarz J, Quackenbush E, Lewis B, Rose SR, Greene S, Toschlog EA, Charlton NP, Mullins ME, Schwartz R, Denning D, Sharma K, Kleinschmidt K, Bush SP, Anderson VE, Ginde AA, Gerardo CJ. Recovery from Copperhead Snake Envenomation: Role of Age, Sex, Bite Location, Severity, and Treatment. J Med Toxicol. 2020 01; 16(1):17-23.
Score: 0.633
-
Lavonas EJ, Anderson VE, Gerardo CJ. In reply to Dr. Shah and Dr. Beuhler. Clin Toxicol (Phila). 2020 03; 58(3):223-224.
Score: 0.628
-
Gerardo CJ, Vissoci JRN, Evans CS, Simel DL, Lavonas EJ. Does This Patient Have a Severe Snake Envenomation?: The Rational Clinical Examination Systematic Review. JAMA Surg. 2019 04 01; 154(4):346-354.
Score: 0.615
-
Gerardo CJ, Vissoci JRN, de Oliveira LP, Anderson VE, Quackenbush E, Lewis B, Rose SR, Greene S, Toschlog EA, Charlton NP, Mullins ME, Schwartz R, Denning D, Sharma K, Kleinschmidt K, Bush SP, Brandehoff NP, Lavonas EJ. The validity, reliability and minimal clinically important difference of the patient specific functional scale in snake envenomation. PLoS One. 2019; 14(3):e0213077.
Score: 0.612
-
Lavonas EJ, Anderson VE, Gerardo CJ. Response to carpenter and colleagues. Clin Toxicol (Phila). 2019 07; 57(7):674-676.
Score: 0.610
-
Mullins ME, Gerardo CJ, Bush SP, Rose SR, Greene S, Quackenbush EB, Lewis B, Anderson VE, Kleinschmidt KC, Schwarz RB, Charlton NP, Toschlog EA, Sharma K, Denning DA, Lavonas EJ. Adverse Events in the Efficacy of Crotalidae Polyvalent Immune Fab Antivenom vs Placebo in Recovery from Copperhead Snakebite Trial. South Med J. 2018 12; 111(12):716-720.
Score: 0.601
-
Lavonas EJ, Gerardo CJ. Letter to the editor: "Safety of nonsteroidal anti-inflammatory drugs in copperhead snakebite patients" by Pham and Mullins, Clin Toxicol 2018 May 18. Clin Toxicol (Phila). 2019 02; 57(2):144-145.
Score: 0.595
-
Anderson VE, Gerardo CJ, Rapp-Olsson M, Bush SP, Mullins ME, Greene S, Toschlog EA, Quackenbush E, Rose SR, Schwartz RB, Charlton NP, Lewis B, Kleinschmidt KC, Sharma K, Lavonas EJ. Early administration of Fab antivenom resulted in faster limb recovery in copperhead snake envenomation patients. Clin Toxicol (Phila). 2019 01; 57(1):25-30.
Score: 0.591
-
Gerardo CJ, Quackenbush E, Lewis B, Rose SR, Greene S, Toschlog EA, Charlton NP, Mullins ME, Schwartz R, Denning D, Sharma K, Kleinschmidt K, Bush SP, Ryan S, Gasior M, Anderson VE, Lavonas EJ. The Efficacy of Crotalidae Polyvalent Immune Fab (Ovine) Antivenom Versus Placebo Plus Optional Rescue?Therapy on Recovery From Copperhead Snake Envenomation: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial. Ann Emerg Med. 2017 Aug; 70(2):233-244.e3.
Score: 0.543
-
Lavonas EJ, Gerardo CJ. Prospective study of recovery from copperhead snake envenomation: an observational study. BMC Emerg Med. 2015 May 15; 15:9.
Score: 0.470
-
Gerardo CJ, Evans CS, Kuchibhatla M, Mando-Vandrick J, Drake WG, Yen M, Kopec K, Lavonas EJ. Time to antivenom administration is not associated with total antivenom dose administered in a copperhead-predominant snakebite population. Acad Emerg Med. 2015 Mar; 22(3):308-14.
Score: 0.463
-
Toschlog EA, Bauer CR, Hall EL, Dart RC, Khatri V, Lavonas EJ. Surgical considerations in the management of pit viper snake envenomation. J Am Coll Surg. 2013 Oct; 217(4):726-35.
Score: 0.415
-
Lavonas EJ, Khatri V, Daugherty C, Bucher-Bartelson B, King T, Dart RC. Medically significant late bleeding after treated crotaline envenomation: a systematic review. Ann Emerg Med. 2014 Jan; 63(1):71-78.e1.
Score: 0.406
-
Lavonas EJ. Antivenoms for snakebite: design, function, and controversies. Curr Pharm Biotechnol. 2012 Aug; 13(10):1980-6.
Score: 0.388
-
Schaeffer TH, Khatri V, Reifler LM, Lavonas EJ. Incidence of immediate hypersensitivity reaction and serum sickness following administration of Crotalidae polyvalent immune Fab antivenom: a meta-analysis. Acad Emerg Med. 2012 Feb; 19(2):121-31.
Score: 0.374
-
Lavonas EJ, Ruha AM, Banner W, Bebarta V, Bernstein JN, Bush SP, Kerns WP, Richardson WH, Seifert SA, Tanen DA, Curry SC, Dart RC. Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop. BMC Emerg Med. 2011 Feb 03; 11:2.
Score: 0.349
-
Lavonas EJ, Kokko J, Schaeffer TH, Mlynarchek SL, Bogdan GM, Dart RC. Short-term outcomes after Fab antivenom therapy for severe crotaline snakebite. Ann Emerg Med. 2011 Feb; 57(2):128-137.e3.
Score: 0.342
-
Lavonas EJ, Schaeffer TH, Kokko J, Mlynarchek SL, Bogdan GM. Crotaline Fab antivenom appears to be effective in cases of severe North American pit viper envenomation: an integrative review. BMC Emerg Med. 2009 Jun 22; 9:13.
Score: 0.312
-
Lavonas EJ, Gerardo CJ, O'Malley G, Arnold TC, Bush SP, Banner W, Steffens M, Kerns WP. Initial experience with Crotalidae polyvalent immune Fab (ovine) antivenom in the treatment of copperhead snakebite. Ann Emerg Med. 2004 Feb; 43(2):200-6.
Score: 0.215
-
Abouyannis M, Esmail H, Hamaluba M, Ngama M, Mwangudzah H, Mumba N, Yeri BK, Mwalukore S, Alphan HJ, Aggarwal D, Alcoba G, Cammack N, Chippaux JP, Coldiron ME, Guti?rrez JM, Habib AG, Harrison RA, Isbister GK, Lavonas EJ, Martins D, Ribeiro I, Watson JA, Williams DJ, Casewell NR, Walker SA, Lalloo DG. [A global core outcome measurement set for snakebite clinical trials]. Med Trop Sante Int. 2023 09 30; 3(3).
Score: 0.209
-
Abouyannis M, Esmail H, Hamaluba M, Ngama M, Mwangudzah H, Mumba N, Yeri BK, Mwalukore S, Alphan HJ, Aggarwal D, Alcoba G, Cammack N, Chippaux JP, Coldiron ME, Guti?rrez JM, Habib AG, Harrison RA, Isbister GK, Lavonas EJ, Martins D, Ribeiro I, Watson JA, Williams DJ, Casewell NR, Walker SA, Lalloo DG. A global core outcome measurement set for snakebite clinical trials. Lancet Glob Health. 2023 02; 11(2):e296-e300.
Score: 0.201
-
Lavonas EJ, Tomaszewski CA, Ford MD, Rouse AM, Kerns WP. Severe puff adder (Bitis arietans) envenomation with coagulopathy. J Toxicol Clin Toxicol. 2002; 40(7):911-8.
Score: 0.186
-
Tupetz A, Phillips AJ, Kelly PE, Barcenas LK, Lavonas EJ, Vissoci JRN, Gerardo CJ. Contextualizing the Impact of Snakebite Envenoming on Patients: A Qualitative Content Analysis of Patient-Specific Functional Scale Activities Using the International Classification of Functioning, Disability and Health. Int J Environ Res Public Health. 2021 09 12; 18(18).
Score: 0.182
-
Theophanous RG, Vissoci JRN, Wen FH, Griffin SM, Anderson VE, Mullins ME, Brandehoff NP, Quackenbush EB, Bush SP, Toschlog EA, Greene SC, Sharma K, Kleinschmidt K, Charlton NP, Rose SR, Schwartz R, Lewis B, Lavonas EJ, Gerardo CJ. Validity and reliability of telephone administration of the patient-specific functional scale for the assessment of recovery from snakebite envenomation. PLoS Negl Trop Dis. 2019 12; 13(12):e0007935.
Score: 0.161
-
Freiermuth CE, Lavonas EJ, Anderson VE, Kleinschmidt KC, Sharma K, Rapp-Olsson M, Gerardo C. Antivenom Treatment Is Associated with Fewer Patients using Opioids after Copperhead Envenomation. West J Emerg Med. 2019 May; 20(3):497-505.
Score: 0.154
-
Gerardo CJ, Lavonas EJ, McKinney RE. Ethical considerations in design of a study to evaluate a US Food and Drug Administration-approved indication: antivenom versus placebo for copperhead envenomation. Clin Trials. 2014 Oct; 11(5):560-4.
Score: 0.111
-
Yin S, Kokko J, Lavonas E, Mlynarchek S, Bogdan G, Schaeffer T. Factors associated with difficulty achieving initial control with crotalidae polyvalent immune fab antivenom in snakebite patients. Acad Emerg Med. 2011 Jan; 18(1):46-52.
Score: 0.087
-
Thorson A, Lavonas EJ, Rouse AM, Kerns WP. Copperhead envenomations in the Carolinas. J Toxicol Clin Toxicol. 2003; 41(1):29-35.
Score: 0.050
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|